LMAT logo

LMAT

LeMaitre Vascular, Inc.NASDAQHealthcare
$108.49-0.24%ClosedMarket Cap: $2.47B

As of 2026-04-06

Valuation

View Details

P/E (TTM)

42.80

PEG

1.38

P/B

6.30

P/S

9.96

EV/EBITDA

29.12

DCF Value

$87.44

FCF Yield

3.0%

Div Yield

0.8%

Margins & Returns

Gross Margin

71.5%

Operating Margin

27.2%

Net Margin

23.1%

ROE

15.6%

ROA

9.4%

ROIC

9.0%

Financials

View All
PeriodRevenueNet IncomeEPS
Q4 2025$64.5M$15.6M$0.68
FY 2025$249.6M$57.7M$2.52
Q3 2025$61.0M$17.4M$0.75
Q2 2025$64.2M$13.8M$0.60

Analyst Ratings

View All
Roth CapitalBuy
2026-02-26
CitizensMarket Outperform
2026-02-26
Wells FargoEqual Weight
2026-02-26
Barrington ResearchOutperform
2026-02-26
Wells FargoEqual Weight
2025-11-07

Trading Activity

Insider Trades

View All
Ross Bridget Adirector
SellMon Mar 30
SHADAN MARTHAdirector
SellMon Mar 30
SHADAN MARTHAdirector
SellMon Mar 30
Ross Bridget Adirector
SellMon Mar 30
Kamke Trent Gofficer: Senior V. P., Operations
SellFri Mar 13

Company Info

Sector

Healthcare

Industry

Country

US

Exchange

NASDAQ

Beta

0.67

LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, it offers valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular and cardiac patches, which are used for closure of vessels after surgical intervention; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

Peers